| Veganuary | 60.0 | 9 | 0 |
| Prozis | 55.9 | 2 | 2 |
| Bodybuilding.com | 45.9 | 2 | 1 |
| Plant Based News | 45.9 | 2 | 1 |
| dietary supplement | 40.0 | 0 | 4 |
| GNC | 35.3 | 1 | 1 |
| The Vitamin Shoppe | 35.3 | 1 | 1 |
| Vega | 35.3 | 1 | 1 |
| Super Supplements | 35.3 | 1 | 1 |
| Naked Nutrition | 35.3 | 1 | 1 |
| True Protein | 35.3 | 1 | 1 |
| BJSM reviews: A-Z of nutritional supplements: dietary supplements, sports nutrition foods and Ergogenic aids for health and performance Part 3. | 34.5 | 0 | 3 |
| BJSM reviews: A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 4. | 34.5 | 0 | 3 |
| BJSM reviews: A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 5. | 34.5 | 0 | 3 |
| BJSM reviews: a--z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance part 7. | 34.5 | 0 | 3 |
| BJSM reviews: A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance part 8. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 9. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance--part 10. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 11. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance--part 12. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance--Part 13. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 14. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: part 15. | 34.5 | 0 | 3 |
| BJSM reviews: A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance--Part 16. | 34.5 | 0 | 3 |
| BJSM reviews: A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance. Part 17. | 34.5 | 0 | 3 |
| BJSMreviews: A to Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance—Part 18 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance—Part 19: Table 1 | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance-Part 20. | 34.5 | 0 | 3 |
| A to Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance--Part 21. | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance—Part 22 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance—Part 23 | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: part 24. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance - part 25. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance--part 26. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance--Part 27. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance - part 28. | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance--Part 29. | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance—Part 30 | 34.5 | 0 | 3 |
| A to Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance—Part 31 | 34.5 | 0 | 3 |
| A to Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: part 32. | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance—Part 33 | 34.5 | 0 | 3 |
| A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance-Part 34. | 34.5 | 0 | 3 |
| BJSM reviews: A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 6: Table 1 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 40: Table 1 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 41 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 42 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 43 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 44: Table 1 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 45 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 46 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 47 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 48 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance – Part 35 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance—Part 37 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 36 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 38 | 34.5 | 0 | 3 |
| A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: part 39: Table 1 | 34.5 | 0 | 3 |
| Nutritional Supplement, Eccentric Exercise and Recovery | 34.5 | 0 | 3 |
| Investigating appropriate molecular and chemical methods for ingredient identity testing of plant-based protein powder dietary supplements | 34.5 | 0 | 3 |
| Bioavailability of Plant Protein Amino Acids | 34.5 | 0 | 3 |
| Fuel Supplements | 34.5 | 0 | 3 |
| Target Corporation | 28.6 | 2 | 0 |
| Trustpilot | 28.6 | 2 | 0 |
| multivitamin | 27.3 | 0 | 2 |
| BioSteel Sports Supplements Inc. | 27.3 | 0 | 2 |
| Dietary Supplements | 27.3 | 0 | 2 |
| Journal of Dietary Supplements | 27.3 | 0 | 2 |
| Pea protein | 27.3 | 0 | 2 |
| Amino Acids | 27.3 | 0 | 2 |
| Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future | 27.3 | 0 | 2 |
| Plant based dietary supplement increases urinary pH | 27.3 | 0 | 2 |
| Dietary Supplements and Sports Performance: Amino Acids | 27.3 | 0 | 2 |
| Evaluation series on safety and efficacy of nutritional supplements in newly diagnosed hyperglycemia: A placebo-controlled, randomized study | 27.3 | 0 | 2 |
| Dietary supplement use among health care professionals enrolled in an online curriculum on herbs and dietary supplements | 27.3 | 0 | 2 |
| Effects of a nutritional supplement containing Salacia oblonga extract and insulinogenic amino acids on postprandial glycemia, insulinemia, and breath hydrogen responses in healthy adults | 27.3 | 0 | 2 |
| Scientific facts behind creatine monohydrate as sport nutrition supplement | 27.3 | 0 | 2 |
| Knowledge and use of dietary supplements by students of College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria | 27.3 | 0 | 2 |
| The Metabolizable Energy Value, Standardized Ileal Digestibility of Amino Acids in Soybean Meal, Soy Protein Concentrate and Fermented Soybean Meal, and the Application of These Products in Early-weaned Piglets | 27.3 | 0 | 2 |
| Clinical pharmacology of the dietary supplement creatine monohydrate. | 27.3 | 0 | 2 |
| Progress in development of an integrated dietary supplement ingredient database at the NIH Office of Dietary Supplements | 27.3 | 0 | 2 |
| Progress in developing analytical and label-based dietary supplement databases at the NIH Office of Dietary Supplements | 27.3 | 0 | 2 |
| Regulation of dietary supplements in the United States: understanding the dietary supplement health and education act. | 27.3 | 0 | 2 |
| Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography | 27.3 | 0 | 2 |
| Determination of designer doping agent – 2-ethylamino-1-phenylbutane – in dietary supplements and excretion study following single oral supplement dose | 27.3 | 0 | 2 |
| Knowledge, Attitude and Practice of Pharmacists regarding Dietary Supplements : A Community Pharmacy- based survey in Tehran | 27.3 | 0 | 2 |
| Rumen Degradability and Post-ruminal Digestion of Dry Matter, Nitrogen and Amino Acids of Three Protein Supplements | 27.3 | 0 | 2 |
| Development and validation of an ultra‐performance liquid chromatography method for simultaneous analysis of 20 antihistaminics in dietary supplements | 27.3 | 0 | 2 |
| Quantitation of underivatized branched-chain amino acids in sport nutritional supplements by capillary electrophoresis with direct or indirect UV absorbance detection | 27.3 | 0 | 2 |
| Rumen Degradability and Small Intestinal Digestibility of the Amino Acids in Four Protein Supplements | 27.3 | 0 | 2 |
| The effects of pre versus post workout supplementation of creatine monohydrate on body composition and strength | 27.3 | 0 | 2 |
| Need for accurate and standardized determination of amino acids and bioactive peptides for evaluating protein quality and potential health effects of foods and dietary supplements. | 27.3 | 0 | 2 |
| Four Weeks of Supplementation With Isolated Soy Protein Attenuates Exercise-Induced Muscle Damage and Enhances Muscle Recovery in Well Trained Athletes: A Randomized Trial | 27.3 | 0 | 2 |
| Effects of a Pre-workout Supplement on Lean Mass, Muscular Performance, Subjective Workout Experience and Biomarkers of Safety | 27.3 | 0 | 2 |
| BJSM reviews: A-Z of supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 2. | 27.3 | 0 | 2 |
| Quality Assurance Issues in the Use of Dietary Supplements, with Special Reference to Protein Supplements | 27.3 | 0 | 2 |
| Dietary Supplements and Medical Foods for Osteopenia and Osteoporosis | 27.3 | 0 | 2 |
| Nutritional evaluation of rapeseed protein compared to soy protein for quality, plasma amino acids, and nitrogen balance – A randomized cross-over intervention study in humans | 27.3 | 0 | 2 |
| Variability of Stimulant Levels in Nine Sports Supplements Over a 9-Month Period | 27.3 | 0 | 2 |
| Timing, Optimal Dose and Intake Duration of Dietary Supplements with Evidence-Based Use in Sports Nutrition. | 27.3 | 0 | 2 |
| Clinical and legal aspects of nonphysician prescription of vitamins, amino acids and other nutritional supplements | 27.3 | 0 | 2 |
| Clinical use of amino acids as dietary supplement: pros and cons | 27.3 | 0 | 2 |
| Prevalence, Adverse Events, and Factors Associated with Dietary Supplement and Nutritional Supplement Use by US Navy and Marine Corps Personnel | 27.3 | 0 | 2 |
| Determinants of dietary supplement use--healthy individuals use dietary supplements | 27.3 | 0 | 2 |
| Plasma amino acids and cholesterol following consumption of dietary casein or soy protein in minipigs | 27.3 | 0 | 2 |
| The effect of plant protein-based diet supplemented with dipeptide or free amino acids on digestive tract morphology and PepT1 and PepT2 expressions in common carp (Cyprinus carpio L.). | 27.3 | 0 | 2 |
| Ileal digestibility of amino acids of unheated and autoclaved pea protein concentrate in broilers | 27.3 | 0 | 2 |
| Effect of metformin therapy and dietary supplements on semen parameters in hyperinsulinaemic males | 27.3 | 0 | 2 |
| Determination of underivatized amino acid delta(13)C by liquid chromatography/isotope ratio mass spectrometry for nutritional studies: the effect of dietary non-essential amino acid profile on the isotopic signature of individual amino acids in fish | 27.3 | 0 | 2 |
| Egg and whole-body amino acid profile of African bonytongue (Heterotis niloticus) with an estimation of their dietary indispensable amino acids requirements | 27.3 | 0 | 2 |
| Zinc increases the effects of essential amino acids-whey protein supplements in frail elderly | 27.3 | 0 | 2 |
| Development of an in-capillary derivatization method by CE for the determination of chiral amino acids in dietary supplements and wines | 27.3 | 0 | 2 |
| Hypercatabolic syndrome: molecular basis and effects of nutritional supplements with amino acids | 27.3 | 0 | 2 |
| Ileal digestibility of amino acids in pea protein isolates, wheat-corn distillers dried grains with solubles, and short-season corn fed to broiler chicks | 27.3 | 0 | 2 |
| Speciation analysis of arsenic in prenatal and children's dietary supplements using microwave-enhanced extraction and ion chromatography–inductively coupled plasma mass spectrometry | 27.3 | 0 | 2 |
| Short-Communication: A Comparison of the In Vitro Angiotensin-1-Converting Enzyme Inhibitory Capacity of Dairy and Plant Protein Supplements. | 27.3 | 0 | 2 |
| Lower Weight Gain and Hepatic Lipid Content in Hamsters Fed High Fat Diets Supplemented with White Rice Protein, Brown Rice Protein, Soy Protein, and their Hydrolysates | 27.3 | 0 | 2 |
| Replacing dietary nonessential amino acids with ammonia nitrogen does not alter amino acid profile of deposited protein in the carcass of growing pigs fed a diet deficient in nonessential amino acid nitrogen1 | 27.3 | 0 | 2 |
| Biological value of proteins in relation to the essential amino acids which they contain; interconvertibility of biological values illustrated by supplementing egg and soy protein with essential amino acids | 27.3 | 0 | 2 |
| Satiating effect of proteins in healthy subjects: a comparison of egg albumin, casein, gelatin, soy protein, pea protein, and wheat gluten | 27.3 | 0 | 2 |
| Twenty Years of the Dietary Supplement Health and Education Act—How Should Dietary Supplements Be Regulated? , | 27.3 | 0 | 2 |
| Has a mixture of amino acids and micronutrients influence on glucose metabolism and dietary fatty acid pattern in chronic psychosocially stressed persons? A pilot study | 27.3 | 0 | 2 |
| Computer access to research on dietary supplements: a database of federally funded dietary supplement research | 27.3 | 0 | 2 |
| Free Amino Acid Profile and Expression of Genes Implicated in Protein Metabolism in Skeletal Muscle of Growing Pigs Fed Low-Protein Diets Supplemented with Branched-Chain Amino Acids. | 27.3 | 0 | 2 |
| Digestibility of energy, amino acids, and phosphorus in a novel source of soy protein concentrate and in soybean meal fed to growing pigs | 27.3 | 0 | 2 |
| Effect of glyburide andω3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus | 27.3 | 0 | 2 |
| Substitution of mixed amino acids resembling soy protein for mixed amino acids resembling casein in the diet reduces plasma cholesterol in slowly, but not rapidly fed nor fasted baboons | 27.3 | 0 | 2 |
| Nutritional Supplements for the Treatment and Prevention of Sports-Related Concussion - Omega 3 Fatty Acids: Evidence Still Lacking? | 27.3 | 0 | 2 |
| Altered peripheral amino acid profile indicate a systemic impact of active celiac disease and a possible role of amino acids in disease pathogenesis | 27.3 | 0 | 2 |
| Utilization of soy protein isolate mixed with rice protein in Japanese women | 27.3 | 0 | 2 |
| LC-ESI-MS/MS analysis of phosphodiesterase-5 inhibitors and their analogues in foods and dietary supplements in Korea | 27.3 | 0 | 2 |
| Whey and soy protein supplements changes body composition in patients with Crohn's disease undergoing azathioprine and anti-TNF-alpha therapy | 27.3 | 0 | 2 |
| Determination of selected biogenic amines in Acacia rigidula plant materials and dietary supplements using LC–MS/MS methods | 27.3 | 0 | 2 |
| Regulation of the plasma amino acid profile by leucine via the system L amino acid transporter | 27.3 | 0 | 2 |
| Protein type and caloric density of protein supplements modulate postprandial amino acid profile through changes in gastrointestinal behaviour: A randomized trial | 27.3 | 0 | 2 |
| Self-Reported Use and Reasons among the General Population for Using Sports Nutrition Products and Dietary Supplements. | 27.3 | 0 | 2 |
| Clinical and biological activity of soy protein powder supplementation in healthy male volunteers | 27.3 | 0 | 2 |
| Ileal digestibility of amino acids in conventional, fermented, and enzyme-treated soybean meal and in soy protein isolate, fish meal, and casein fed to weanling pigs | 27.3 | 0 | 2 |
| Supplement Regulation for Sports Nutrition Supplements | 27.3 | 0 | 2 |
| Highly sensitive on-site detection of drugs adulterated in botanical dietary supplements using thin layer chromatography combined with dynamic surface enhanced Raman spectroscopy | 27.3 | 0 | 2 |
| BJSM reviews: A-Z of supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 1 | 27.3 | 0 | 2 |
| Determination of Amino Acids in Plasma and Nutritional Supplements by Capillary Electrophoresis with Copper(II) Coordination | 27.3 | 0 | 2 |
| Rapid assessment of the illegal presence of 1,3-dimethylamylamine (DMAA) in sports nutrition and dietary supplements using1H NMR spectroscopy | 27.3 | 0 | 2 |
| Evaluation of bioavailability of individual amino acids in Diplodus puntazzo larvae: Towards the ideal dietary amino acid profile | 27.3 | 0 | 2 |
| Effect of a leucine-enriched essential amino acids mixture on muscle recovery | 27.3 | 0 | 2 |
| Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment | 27.3 | 0 | 2 |
| Comparison of Plant and Animal Proteins on Amino Acid Concentrations | 27.3 | 0 | 2 |
| Nutritional Supplement Compliance Study | 27.3 | 0 | 2 |
| Intravenous Chemotherapy and Plant-based Dietary Supplements | 27.3 | 0 | 2 |
| Effects of Dietary Supplements on Response to Air Pollution | 27.3 | 0 | 2 |
| Dietary Supplements and Aging Muscle | 27.3 | 0 | 2 |
| Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye | 27.3 | 0 | 2 |
| Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical Patients | 27.3 | 0 | 2 |
| BCAA's in Concussion | 27.3 | 0 | 2 |
| Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer | 27.3 | 0 | 2 |
| A Study of an Oral Nutritional Supplement in a Malnourished Population With GI Tolerance Impairment | 27.3 | 0 | 2 |
| Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer | 27.3 | 0 | 2 |
| Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial) | 27.3 | 0 | 2 |
| Appearance of Plasma Amino Acids Following Consumption of an Oral Nutrition Supplement | 27.3 | 0 | 2 |
| Effect of oral or caecal administration of protein supplements on equine plasma amino acids | 27.3 | 0 | 2 |
| Nitrogen Retention in Men Fed Varying Levels of Amino Acids from Soy Protein with or without Added L-Methionine | 27.3 | 0 | 2 |
| Difference of plasma amino acids following casein or soy protein intake: significance for differences of serum lipid concentrations | 27.3 | 0 | 2 |
| Comparative studies on soy protein and rice protein for cholesterol metabolism in rats | 27.3 | 0 | 2 |
| Urinary calcium and calcium balance in young women affected by high protein diet of soy protein isolate and adding sulfur-containing amino acids and/or potassium | 27.3 | 0 | 2 |
| The effect of dietary supplements of omega 3 polyunsaturated fatty acids on the fatty acid composition of platelets and plasma choline phosphoglycerides | 27.3 | 0 | 2 |
| Effect of the content of crude plant protein in feed on the utilization of urea in dairy cattle. 4. Passage of amino acids through the duodenum | 27.3 | 0 | 2 |
| Safety of amino acids used as dietary supplements | 27.3 | 0 | 2 |
| Efficiency of utilization of free amino acids given as dietary supplements to the rat | 27.3 | 0 | 2 |
| Plasma Amino Acids and Nitrogen Retention by Steers Fed Purified Diets Containing Urea or Isolated Soy Protein | 27.3 | 0 | 2 |
| Corn distillers grains versus a blend of protein supplements with or without ruminally protected amino acids for lactating cows | 27.3 | 0 | 2 |
| Nutritional and clinical evaluation of a modified soy protein with covalently bound branched-chain amino acids in cirrhotic sprague-dawley rats | 27.3 | 0 | 2 |
| Dietary supplements of mixtures of indispensable amino acids lacking threonine, phenylalanine or histidine increase the activity of hepatic threonine dehydrogenase, phenylalanine hydroxylase or histidase, respectively, and prevent growth depressions | 27.3 | 0 | 2 |
| USE OF amino acids as dietary supplements; amino acid imbalance and lysine | 27.3 | 0 | 2 |
| Bioavailability of Protein and Amino Acids of Pea Protein Isolate in Healthy Volunteers | 27.3 | 0 | 2 |
| FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update | 27.3 | 0 | 2 |
| Guidelines for the promotion of dietary supplements: examining government regulation five years after enactment of the Dietary Supplement Health and Education Act of 1994 | 27.3 | 0 | 2 |
| [Experimental studies on the relationship between hepatic succinic dehydrogenase and nutrition in weaning albino mice. 3. Effect of supplementation by amino acids of polished rice protein] | 27.3 | 0 | 2 |
| The Dietary Supplement and Health Education Act and Supplements: Dietary and Nutritional Supplements Need No More Regulations | 27.3 | 0 | 2 |
| Supplementation of soy protein with branched-chain amino acids alters protein metabolism in healthy elderly and even more in patients with chronic obstructive pulmonary disease | 27.3 | 0 | 2 |
| Application of the indicator amino acid oxidation technique for the determination of metabolic availability of sulfur amino acids from casein versus soy protein isolate in adult men | 27.3 | 0 | 2 |
| Accurate methodology for amino acids and bioactive peptides in functional foods and dietary supplements for assessing protein adequacy and health effects | 27.3 | 0 | 2 |
| Influence of the Dietary Supplement Health and Education Act on Consumer Beliefs About the Safety and Effectiveness of Dietary Supplements | 27.3 | 0 | 2 |
| Quantitative analysis of amino acids in dietary supplements using terahertz time-domain spectroscopy | 27.3 | 0 | 2 |
| UHPLC–UV method for the determination of flavonoids in dietary supplements and for evaluation of their antioxidant activities | 27.3 | 0 | 2 |
| Partially Hydrolyzed Soy Protein Shows Enhanced Transport of Amino Acids Compared to Nonhydrolyzed Protein across an Intestinal Epithelial Cell Monolayer | 27.3 | 0 | 2 |
| A comparison of actual versus stated label amounts of EPA and DHA in commercial omega-3 dietary supplements in the United States | 27.3 | 0 | 2 |
| Contribution of cationic amino acids toward the inhibition of Arg‐specific cysteine proteinase (Arg‐gingipain) by the antimicrobial dodecapeptide, CL(14–25), from rice protein | 27.3 | 0 | 2 |
| Effect of glycine supplementation in low protein diets with amino acids from soy protein isolate or free amino acids on broiler growth and nitrogen utilisation | 27.3 | 0 | 2 |
| protein powder | 27.3 | 0 | 2 |
| Nutritional Supplements: Certification programs to ensure quality dietary supplements | 27.3 | 0 | 2 |
| Selective chemical modification of soy protein for a tough and applicable plant protein-based material | 27.3 | 0 | 2 |
| A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Nutritional Supplement Lumenato and Its Impact on Skin Parameters in Healthy Female Subjects | 27.3 | 0 | 2 |
| The Effect of Branched Chain Amino Acids-Enriched Nutritional Supplements on Activities of Daily Living and Muscle Mass in Inpatients with Gait Impairments: A Randomized Controlled Trial | 27.3 | 0 | 2 |
| Gum Arabic-Mediated Synthesis of Glyco-pea Protein Hydrolysate via Maillard Reaction Improves Solubility, Flavor Profile, and Functionality of Plant Protein | 27.3 | 0 | 2 |
| Branched-chain amino acids do not improve muscle recovery from resistance exercise in untrained young adults | 27.3 | 0 | 2 |
| Why Do Athletes Choose Dietary Supplements? Reliability and Validity of the Dietary Supplement Choice Questionnaire (DSCQ) among Japanese College Athletes | 27.3 | 0 | 2 |
| Help healthy patients stay healthy. This month: reducing practice aggravation, vegetarians and vitamin B12, who needs vitamin supplements, marathons and hypothermia, effect of vitamin C on cholesterol, how much vitamin C to take, effect of dietary s | 27.3 | 0 | 2 |
| Quantitative Analysis of Branched-chain Amino Acids in Five Nutritional Supplements Using a Leucine Dehydrogenase Assay (P23-004-19) | 27.3 | 0 | 2 |
| Dietary supplement safety. You've heard all the warnings about dietary supplements. Here are a few that men should use with caution or avoid | 27.3 | 0 | 2 |
| Beyond burger | 27.3 | 0 | 2 |
| Microbial Profile of the Ventriculum of Honey Bee (Apis mellifera ligustica Spinola, 1806) Fed with Veterinary Drugs, Dietary Supplements and Non-Protein Amino Acids | 27.3 | 0 | 2 |
| A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study | 27.3 | 0 | 2 |
| Effects of Pre-Sleep Whey vs. Plant-Based Protein Consumption on Muscle Recovery Following Damaging Morning Exercise | 27.3 | 0 | 2 |
| Influence of Eimeria spp. infection and dietary inclusion of arginine on intestine histological parameters, serum amino acid profile and ileal amino acids digestibility in broiler chicks | 27.3 | 0 | 2 |
| In Vivo Effect of Resveratrol-Loaded Solid Lipid Nanoparticles to Relieve Physical Fatigue for Sports Nutrition Supplements | 27.3 | 0 | 2 |
| Postprandial Amino Acid Response After Protein Consumption | 27.3 | 0 | 2 |
| Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy | 27.3 | 0 | 2 |
| Effect on wool growth of dietary supplements of normal and treated casein | 27.3 | 0 | 2 |
| Effect of various whey protein supplements on recovery from prolonged endurance exercise in trained cyclists | 27.3 | 0 | 2 |
| The effect of fish protein powder on the physiochemical, nutritional and sensory properties of cereal based products | 27.3 | 0 | 2 |
| EVALUATION OF RAPESEED FLOUR AND PEA PROTEIN CONCENTRATE AS PROTEIN SUPPLEMENTS FOR HONEY BEES (HYMENOPTERA: APIDAE) | 27.3 | 0 | 2 |
| Functional characterization of high-yield plant protein powder valorized from de-oiled sour cherry seed using microwave-assisted enzymatic extraction followed by spray- and freeze-drying | 27.3 | 0 | 2 |
| Amino acid profile of the peel of three citrus species and its effect on the combination of amino acids and fatty acids Chlorella vulgaris | 27.3 | 0 | 2 |
| Vitaminstore | 27.3 | 0 | 2 |
| Complete Replacement of Fishmeal With Plant Protein Ingredients in Gibel Carp (Carassius auratus gibelio) Diets by Supplementation With Essential Amino Acids Without Negative Impact on Growth Performance and Muscle Growth-Related Biomarkers | 27.3 | 0 | 2 |
| Nutritional Supplement for Athletic Performance: Based on Australian Institute of Sport Sports Supplement Framework | 27.3 | 0 | 2 |
| In vitro digestion of protein-enriched restructured beef steaks with pea protein isolate, rice protein and lentil flour following sous vide processing | 27.3 | 0 | 2 |
| LATAM: Plant protein in bakery, snacks, and sports nutrition | 27.3 | 0 | 2 |
| Study of amino acids absorption and gut microbiome on consumption of pea protein blended with enzymes-probiotics supplement | 27.3 | 0 | 2 |
| Amino acids release from enriched bread with edible insect or pea protein during in vitro gastrointestinal digestion | 27.3 | 0 | 2 |
| Amino acids and proteinin vitro bio-accessibility from edible insect and pea protein enriched bread | 27.3 | 0 | 2 |
| The New Challenge of Sports Nutrition: Accepting Insect Food as Dietary Supplements in Professional Athletes | 27.3 | 0 | 2 |
| Q134608388 | 27.3 | 0 | 2 |
| Elite Supplements | 27.3 | 0 | 2 |
| WaySport | 27.3 | 0 | 2 |
| Protein network density and fibrous structure control of soy protein isolate-based high-moisture meat analogs using yeast or rice protein isolates with distinct glass transition temperatures | 27.3 | 0 | 2 |
| Jacked Nutrition | 27.3 | 0 | 2 |
| Wise Choice Supplements | 27.3 | 0 | 2 |
| Granite Nutrition | 27.3 | 0 | 2 |
| ESN | 27.3 | 0 | 2 |
| Zenith Sports | 27.3 | 0 | 2 |
| Vansiton | 27.3 | 0 | 2 |
| Fyzio | 27.3 | 0 | 2 |
| 3VS Nutrition | 27.3 | 0 | 2 |
| Nutrade | 27.3 | 0 | 2 |
| Q483551 | 18.1 | 1 | 0 |
| H-E-B | 18.1 | 1 | 0 |
| VEGA Grieshaber | 18.1 | 1 | 0 |
| Ritual Entertainment | 18.1 | 1 | 0 |
| Whole Foods Market | 18.1 | 1 | 0 |
| The Vegan Society | 18.1 | 1 | 0 |
| Holland & Barrett | 18.1 | 1 | 0 |
| Robert Cheeke | 18.1 | 1 | 0 |
| Sprouts Farmers Market | 18.1 | 1 | 0 |
| Swanson Health Products | 18.1 | 1 | 0 |
| Vitacost | 18.1 | 1 | 0 |
| Vitamin World | 18.1 | 1 | 0 |
| Women's Health | 18.1 | 1 | 0 |
| list of Walmart brands | 18.1 | 1 | 0 |
| Healthspan | 18.1 | 1 | 0 |
| Myprotein | 18.1 | 1 | 0 |
| Huel | 18.1 | 1 | 0 |
| The Protein Works | 18.1 | 1 | 0 |
| Toast, Inc. | 18.1 | 1 | 0 |
| Thrive Market | 18.1 | 1 | 0 |
| protein | 17.2 | 0 | 1 |
| amino acid | 17.2 | 0 | 1 |
| proteolysis | 17.2 | 0 | 1 |
| oxytocin | 17.2 | 0 | 1 |
| vitamin K | 17.2 | 0 | 1 |
| omega-3 fatty acid | 17.2 | 0 | 1 |
| gluconeogenesis | 17.2 | 0 | 1 |
| transfer RNA | 17.2 | 0 | 1 |
| protein biosynthesis | 17.2 | 0 | 1 |
| peptidase | 17.2 | 0 | 1 |
| creatine | 17.2 | 0 | 1 |
| zwitterion | 17.2 | 0 | 1 |
| essential amino acid | 17.2 | 0 | 1 |
| diamino acid | 17.2 | 0 | 1 |
| beta sheet | 17.2 | 0 | 1 |
| spirulina | 17.2 | 0 | 1 |
| cyanophycin | 17.2 | 0 | 1 |
| dipeptide | 17.2 | 0 | 1 |
| branched-chain amino acid | 17.2 | 0 | 1 |
| peptone | 17.2 | 0 | 1 |
| storage protein | 17.2 | 0 | 1 |
| ammonification | 17.2 | 0 | 1 |
| Nutrilite | 17.2 | 0 | 1 |
| Transamination | 17.2 | 0 | 1 |
| aromatic amino acid | 17.2 | 0 | 1 |
| cod liver oil | 17.2 | 0 | 1 |
| catalytic triad | 17.2 | 0 | 1 |
| iron supplement | 17.2 | 0 | 1 |
| melanoidin | 17.2 | 0 | 1 |
| TRX2 | 17.2 | 0 | 1 |
| Strecker amino-acid synthesis | 17.2 | 0 | 1 |
| protein primary structure | 17.2 | 0 | 1 |
| signal peptide | 17.2 | 0 | 1 |
| Slim Fast | 17.2 | 0 | 1 |
| functional beverage | 17.2 | 0 | 1 |
| sports nutrition | 17.2 | 0 | 1 |
| bodybuilding supplement | 17.2 | 0 | 1 |
| condensation reaction | 17.2 | 0 | 1 |
| sports drink | 17.2 | 0 | 1 |
| ethical consumerism | 17.2 | 0 | 1 |
| Q1050182 | 17.2 | 0 | 1 |
| Creatine supplements | 17.2 | 0 | 1 |
| de novo synthesis | 17.2 | 0 | 1 |
| meat alternative | 17.2 | 0 | 1 |
| sense | 17.2 | 0 | 1 |
| organic acidemia | 17.2 | 0 | 1 |
| dog biscuit | 17.2 | 0 | 1 |
| Active Hexose Correlated Compound | 17.2 | 0 | 1 |
| Nu Skin Enterprises | 17.2 | 0 | 1 |
| Haarlem oil | 17.2 | 0 | 1 |
| suet cake | 17.2 | 0 | 1 |
| millrind | 17.2 | 0 | 1 |
| plant based medication | 17.2 | 0 | 1 |
| Salvestrols | 17.2 | 0 | 1 |
| textured vegetable protein | 17.2 | 0 | 1 |
| oligopeptide | 17.2 | 0 | 1 |
| synbiotics | 17.2 | 0 | 1 |
| Ketogenic amino acid | 17.2 | 0 | 1 |
| Wuschel | 17.2 | 0 | 1 |
| glucogenic amino acid | 17.2 | 0 | 1 |
| tryptone | 17.2 | 0 | 1 |
| Klamath Lake AFA | 17.2 | 0 | 1 |
| Atmit | 17.2 | 0 | 1 |
| Proteinoid | 17.2 | 0 | 1 |
| Urech hydantoin synthesis | 17.2 | 0 | 1 |
| amino acid synthesis | 17.2 | 0 | 1 |
| isopeptide bond | 17.2 | 0 | 1 |
| proteinogenic amino acid | 17.2 | 0 | 1 |
| Pearl GTL | 17.2 | 0 | 1 |
| hydrolyzed protein | 17.2 | 0 | 1 |
| Stable isotope labeling by amino acids in cell culture | 17.2 | 0 | 1 |
| non-standard amino acid | 17.2 | 0 | 1 |
| Pervouralsk New Pipe Plant | 17.2 | 0 | 1 |
| ACES | 17.2 | 0 | 1 |
| hydrolyzed vegetable protein | 17.2 | 0 | 1 |
| Airborne | 17.2 | 0 | 1 |
| American Health, Inc. | 17.2 | 0 | 1 |
| Amino acid activation | 17.2 | 0 | 1 |
| Atomidine | 17.2 | 0 | 1 |
| tripeptide | 17.2 | 0 | 1 |
| Beano | 17.2 | 0 | 1 |
| Beta-peptide | 17.2 | 0 | 1 |
| caloric restriction mimetic | 17.2 | 0 | 1 |
| Cancell | 17.2 | 0 | 1 |
| Casamino acid | 17.2 | 0 | 1 |
| Chemical ligation | 17.2 | 0 | 1 |
| Chemins | 17.2 | 0 | 1 |
| complete protein | 17.2 | 0 | 1 |
| CortiSlim | 17.2 | 0 | 1 |
| Cosequin | 17.2 | 0 | 1 |
| CRRC Datong Co., Ltd. | 17.2 | 0 | 1 |
| Dexatrim | 17.2 | 0 | 1 |
| EAS | 17.2 | 0 | 1 |
| Energy gel | 17.2 | 0 | 1 |
| Ensure | 17.2 | 0 | 1 |
| Enzyte | 17.2 | 0 | 1 |
| excitatory amino acid receptor agonist | 17.2 | 0 | 1 |
| excitatory amino acid antagonist | 17.2 | 0 | 1 |
| GU | 17.2 | 0 | 1 |
| Gelonin | 17.2 | 0 | 1 |
| Gentech Pharmaceutical | 17.2 | 0 | 1 |
| Geritol | 17.2 | 0 | 1 |
| GliSODin | 17.2 | 0 | 1 |
| Haven Nuclear Power Plant | 17.2 | 0 | 1 |
| Hopp–Woods scale | 17.2 | 0 | 1 |
| Category:Omega-3 fatty acids | 17.2 | 0 | 1 |
| Lactagen | 17.2 | 0 | 1 |
| Liquid oxygen supplement | 17.2 | 0 | 1 |
| Mannan oligosaccharide-based nutritional supplements | 17.2 | 0 | 1 |
| Template:Proteinogenic amino acids | 17.2 | 0 | 1 |
| Category:Basic amino acids | 17.2 | 0 | 1 |
| Met-Rx | 17.2 | 0 | 1 |
| Mucunain | 17.2 | 0 | 1 |
| MusclePharm | 17.2 | 0 | 1 |
| Juice Plus+ | 17.2 | 0 | 1 |
| non-proteinogenic amino acid | 17.2 | 0 | 1 |
| Ocean Nutrition Canada | 17.2 | 0 | 1 |
| PelB leader sequence | 17.2 | 0 | 1 |
| Pharmavite | 17.2 | 0 | 1 |
| plant-based diet | 17.2 | 0 | 1 |
| Category:Amino acids | 17.2 | 0 | 1 |
| Category:Dietary supplements | 17.2 | 0 | 1 |
| Pro-hevein | 17.2 | 0 | 1 |
| protein supplement | 17.2 | 0 | 1 |
| quack Miranda warning | 17.2 | 0 | 1 |
| Ratios of Omega 3 to Omega 6 in different foods | 17.2 | 0 | 1 |
| Regulation of food and dietary supplements by the U.S. Food and Drug Administration | 17.2 | 0 | 1 |
| rice protein | 17.2 | 0 | 1 |
| Q7361793 | 17.2 | 0 | 1 |
| saw palmetto extract | 17.2 | 0 | 1 |
| Souvenaid | 17.2 | 0 | 1 |
| soy protein | 17.2 | 0 | 1 |
| Statistical coupling analysis | 17.2 | 0 | 1 |
| Sustagen | 17.2 | 0 | 1 |
| sustainable packaging | 17.2 | 0 | 1 |
| tetrapeptide | 17.2 | 0 | 1 |
| TrimSpa | 17.2 | 0 | 1 |
| vegan nutrition | 17.2 | 0 | 1 |
| Category:Acidic amino acids | 17.2 | 0 | 1 |
| Category:Aromatic amino acids | 17.2 | 0 | 1 |
| Category:Branched-chain amino acids | 17.2 | 0 | 1 |
| Category:Essential amino acids | 17.2 | 0 | 1 |
| Category:Cyclic amino acids | 17.2 | 0 | 1 |
| Category:Glucogenic amino acids | 17.2 | 0 | 1 |
| Category:Ketogenic amino acids | 17.2 | 0 | 1 |
| Category:Sports nutrition and bodybuilding supplement companies | 17.2 | 0 | 1 |
| Category:Alpha-Amino acids | 17.2 | 0 | 1 |
| Category:Sulfur amino acids | 17.2 | 0 | 1 |
| plecing kangkung | 17.2 | 0 | 1 |
| Category:Proteinogenic amino acids | 17.2 | 0 | 1 |
| Category:Sports nutrition | 17.2 | 0 | 1 |
| dispensable amino acids | 17.2 | 0 | 1 |
| Category:Beta-Amino acids | 17.2 | 0 | 1 |
| Category:Gamma-Amino acids | 17.2 | 0 | 1 |
| ADE | 17.2 | 0 | 1 |
| decapeptide | 17.2 | 0 | 1 |
| Novit | 17.2 | 0 | 1 |
| alpha-amino acid | 17.2 | 0 | 1 |
| Genacol | 17.2 | 0 | 1 |
| heptapeptide | 17.2 | 0 | 1 |
| hexapeptide | 17.2 | 0 | 1 |
| nonapeptide | 17.2 | 0 | 1 |
| octapeptide | 17.2 | 0 | 1 |
| pentapeptide | 17.2 | 0 | 1 |
| Hydroxycut | 17.2 | 0 | 1 |
| NITRO FX | 17.2 | 0 | 1 |
| Category:B-Class Dietary supplement articles | 17.2 | 0 | 1 |
| Category:C-Class Dietary supplement articles | 17.2 | 0 | 1 |
| Category:Dietary supplement articles by importance | 17.2 | 0 | 1 |
| Category:Dietary supplement articles by quality | 17.2 | 0 | 1 |
| Category:FA-Class Dietary supplement articles | 17.2 | 0 | 1 |
| Category:FL-Class Dietary supplement articles | 17.2 | 0 | 1 |
| Category:GA-Class Dietary supplement articles | 17.2 | 0 | 1 |
| Category:High-importance Dietary supplement articles | 17.2 | 0 | 1 |
| Category:Low-importance Dietary supplement articles | 17.2 | 0 | 1 |
| Category:NA-Class Dietary supplement pages | 17.2 | 0 | 1 |
| Category:NA-importance Dietary supplement pages | 17.2 | 0 | 1 |
| Category:Start-Class Dietary supplement articles | 17.2 | 0 | 1 |
| Category:Stub-Class Dietary supplement articles | 17.2 | 0 | 1 |
| Category:Top-importance Dietary supplement articles | 17.2 | 0 | 1 |
| Category:Unassessed Dietary supplement articles | 17.2 | 0 | 1 |
| Category:WikiProject Dietary Supplements | 17.2 | 0 | 1 |
| Lipids in sports nutrition | 17.2 | 0 | 1 |
| Template:Dietary supplement | 17.2 | 0 | 1 |
| Template:IUPAC-IUB amino acids 1983 | 17.2 | 0 | 1 |
| peptide binding | 17.2 | 0 | 1 |
| regulation of cellular amino acid metabolic process | 17.2 | 0 | 1 |
| neuropeptide hormone activity | 17.2 | 0 | 1 |
| positive regulation of protein phosphorylation | 17.2 | 0 | 1 |
| cellular amino acid biosynthetic process | 17.2 | 0 | 1 |
| aromatic amino acid family metabolic process | 17.2 | 0 | 1 |
| regulation of gluconeogenesis | 17.2 | 0 | 1 |
| cellular amino acid metabolic process | 17.2 | 0 | 1 |
| negative regulation of protein phosphorylation | 17.2 | 0 | 1 |
| peptide catabolic process | 17.2 | 0 | 1 |
| peptide metabolic process | 17.2 | 0 | 1 |
| alkaloid catabolic process | 17.2 | 0 | 1 |
| alkaloid metabolic process | 17.2 | 0 | 1 |
| POU domain binding | 17.2 | 0 | 1 |
| sulfur amino acid metabolic process | 17.2 | 0 | 1 |
| glutathione binding | 17.2 | 0 | 1 |
| amino acid transport | 17.2 | 0 | 1 |
| amino acid transmembrane transport | 17.2 | 0 | 1 |
| L-amino acid transport | 17.2 | 0 | 1 |
| translational initiation | 17.2 | 0 | 1 |
| lipopeptide binding | 17.2 | 0 | 1 |
| creatine metabolic process | 17.2 | 0 | 1 |
| regulation of protein ADP-ribosylation | 17.2 | 0 | 1 |
| branched-chain amino acid catabolic process | 17.2 | 0 | 1 |
| C-X3-C chemokine receptor activity | 17.2 | 0 | 1 |
| beta-endorphin receptor activity | 17.2 | 0 | 1 |
| serine family amino acid metabolic process | 17.2 | 0 | 1 |
| amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| basic amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| basic amino acid transport | 17.2 | 0 | 1 |
| sulfur amino acid catabolic process | 17.2 | 0 | 1 |
| Natural Alternatives International | 17.2 | 0 | 1 |
| Category:WikiProject Dietary Supplements articles | 17.2 | 0 | 1 |
| Category:A-Class Dietary supplement articles | 17.2 | 0 | 1 |
| Category:Unknown-importance Dietary supplement articles | 17.2 | 0 | 1 |
| Category:List-Class Dietary supplement articles | 17.2 | 0 | 1 |
| Category:Mid-importance Dietary supplement articles | 17.2 | 0 | 1 |
| Category:Nutritional supplement companies | 17.2 | 0 | 1 |
| ankyrin repeat binding | 17.2 | 0 | 1 |
| Journal of the International Society of Sports Nutrition | 17.2 | 0 | 1 |
| Clinical Nutrition Supplements | 17.2 | 0 | 1 |
| Nutrition and Dietary Supplements | 17.2 | 0 | 1 |
| Alpha and Omega 3: The Great Wolf Games | 17.2 | 0 | 1 |
| International Society of Sports Nutrition | 17.2 | 0 | 1 |
| weight gainer | 17.2 | 0 | 1 |
| Kabat Numbering Scheme | 17.2 | 0 | 1 |
| Dietary Supplement Health and Education Act of 1994 | 17.2 | 0 | 1 |
| Azerizin | 17.2 | 0 | 1 |
| Fish protein powder | 17.2 | 0 | 1 |
| Juice Plus | 17.2 | 0 | 1 |
| Lipozene | 17.2 | 0 | 1 |
| Sobrietol | 17.2 | 0 | 1 |
| MuscleTech | 17.2 | 0 | 1 |
| hydrophilicity plot | 17.2 | 0 | 1 |
| egg analogue | 17.2 | 0 | 1 |
| Seasilver | 17.2 | 0 | 1 |
| SLC7A5 | 17.2 | 0 | 1 |
| SLC43A1 | 17.2 | 0 | 1 |
| SLC7A8 | 17.2 | 0 | 1 |
| GSTO3P | 17.2 | 0 | 1 |
| Q18208172 | 17.2 | 0 | 1 |
| Omega 3 | 17.2 | 0 | 1 |
| Cellucor | 17.2 | 0 | 1 |
| amino acid metabolic disorder | 17.2 | 0 | 1 |
| Dietary Supplement Access and Awareness Act by Susan Davis | 17.2 | 0 | 1 |
| Zinzino | 17.2 | 0 | 1 |
| A-level Chemistry/AQA/Module 4/Amino Acids | 17.2 | 0 | 1 |
| A-level Chemistry/OCR (Salters)/Amino acids | 17.2 | 0 | 1 |
| STN8 | 17.2 | 0 | 1 |
| AABT | 17.2 | 0 | 1 |
| Plant-mPLoc: a top-down strategy to augment the power for predicting plant protein subcellular localization | 17.2 | 0 | 1 |
| Resolving discrepancy between nucleotides and amino acids in deep-level arthropod phylogenomics: differentiating serine codons in 21-amino-acid models | 17.2 | 0 | 1 |
| peroxisome targeting sequence binding | 17.2 | 0 | 1 |
| cyclosporin A binding | 17.2 | 0 | 1 |
| neutral amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| neutral amino acid transport | 17.2 | 0 | 1 |
| cotranslational protein targeting to membrane | 17.2 | 0 | 1 |
| post-translational protein acetylation | 17.2 | 0 | 1 |
| cellular amino acid catabolic process | 17.2 | 0 | 1 |
| CAAX-box protein processing | 17.2 | 0 | 1 |
| cellular modified amino acid catabolic process | 17.2 | 0 | 1 |
| protein insertion into ER membrane | 17.2 | 0 | 1 |
| cellular response to amino acid starvation | 17.2 | 0 | 1 |
| Krueppel-associated box domain binding | 17.2 | 0 | 1 |
| sulfur compound metabolic process | 17.2 | 0 | 1 |
| negative regulation of protein ADP-ribosylation | 17.2 | 0 | 1 |
| regulation of glutamine family amino acid metabolic process | 17.2 | 0 | 1 |
| protein ADP-ribosylation | 17.2 | 0 | 1 |
| TPR domain binding | 17.2 | 0 | 1 |
| WD40-repeat domain binding | 17.2 | 0 | 1 |
| co-translational protein modification | 17.2 | 0 | 1 |
| cytoplasmic translational initiation | 17.2 | 0 | 1 |
| L27 domain binding | 17.2 | 0 | 1 |
| Solute carrier family 25 member 29 | 17.2 | 0 | 1 |
| branched-chain amino acid biosynthetic process | 17.2 | 0 | 1 |
| serine family amino acid biosynthetic process | 17.2 | 0 | 1 |
| protein modification process | 17.2 | 0 | 1 |
| self proteolysis | 17.2 | 0 | 1 |
| D-amino acid catabolic process | 17.2 | 0 | 1 |
| tRNA metabolic process | 17.2 | 0 | 1 |
| cellular modified amino acid metabolic process | 17.2 | 0 | 1 |
| tRNA catabolic process | 17.2 | 0 | 1 |
| L-amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| Solute carrier family 43 member 1 | 17.2 | 0 | 1 |
| solute carrier family 7 member 5 | 17.2 | 0 | 1 |
| Solute carrier family 43 member 2 | 17.2 | 0 | 1 |
| Solute carrier family 7 member 8 | 17.2 | 0 | 1 |
| creatine transmembrane transporter activity | 17.2 | 0 | 1 |
| aromatic amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| aromatic amino acid transport | 17.2 | 0 | 1 |
| positive regulation of amino acid transport | 17.2 | 0 | 1 |
| GBD domain binding | 17.2 | 0 | 1 |
| Non-standard amino acid incorporation into proteins using Escherichia coli cell-free protein synthesis | 17.2 | 0 | 1 |
| Microseminoprotein beta | 17.2 | 0 | 1 |
| High Levels of Aromatic Amino Acids in Gastric Juice during the Early Stages of Gastric Cancer Progression | 17.2 | 0 | 1 |
| modified amino acid transport | 17.2 | 0 | 1 |
| trace-amine receptor activity | 17.2 | 0 | 1 |
| branched-chain amino acid transport | 17.2 | 0 | 1 |
| Large neutral amino acids transporter small subunit 2 | 17.2 | 0 | 1 |
| Non-natural and photo-reactive amino acids as biochemical probes of immune function | 17.2 | 0 | 1 |
| Neighbor-dependent Ramachandran probability distributions of amino acids developed from a hierarchical Dirichlet process model | 17.2 | 0 | 1 |
| peroxisome membrane class-1 targeting sequence binding | 17.2 | 0 | 1 |
| sulfur amino acid biosynthetic process | 17.2 | 0 | 1 |
| plasma lipoprotein particle oxidation | 17.2 | 0 | 1 |
| serine family amino acid catabolic process | 17.2 | 0 | 1 |
| Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure | 17.2 | 0 | 1 |
| Cystine and theanine: amino acids as oral immunomodulative nutrients | 17.2 | 0 | 1 |
| aromatic amino acid family biosynthetic process | 17.2 | 0 | 1 |
| chorismate biosynthetic process | 17.2 | 0 | 1 |
| branched-chain amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| shikimate metabolic process | 17.2 | 0 | 1 |
| peptide transport | 17.2 | 0 | 1 |
| A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate | 17.2 | 0 | 1 |
| International Society of Sports Nutrition position stand: creatine supplementation and exercise | 17.2 | 0 | 1 |
| U.S. and Canadian pharmacists' attitudes, knowledge, and professional practice behaviors toward dietary supplements: a systematic review | 17.2 | 0 | 1 |
| Amino acids biosynthesis and nitrogen assimilation pathways: a great genomic deletion during eukaryotes evolution | 17.2 | 0 | 1 |
| Evolutionary proteomics identifies amino acids essential for ligand-binding of the cytokinin receptor CHASE domain | 17.2 | 0 | 1 |
| Genome wide exploration of the origin and evolution of amino acids | 17.2 | 0 | 1 |
| Do nutritional supplements have a role in age macular degeneration prevention? | 17.2 | 0 | 1 |
| branched-chain amino acid metabolic process | 17.2 | 0 | 1 |
| circulatory system development | 17.2 | 0 | 1 |
| cytochrome P450, family 4, subfamily a, polypeptide 14 | 17.2 | 0 | 1 |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 | 17.2 | 0 | 1 |
| mitochondrial translation | 17.2 | 0 | 1 |
| mitochondrial translational initiation | 17.2 | 0 | 1 |
| Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment | 17.2 | 0 | 1 |
| pyrroloquinoline quinone biosynthetic process | 17.2 | 0 | 1 |
| WikiProject Dietary Supplements | 17.2 | 0 | 1 |
| WW domain binding | 17.2 | 0 | 1 |
| creatine transmembrane transport | 17.2 | 0 | 1 |
| Solute carrier family 25 (mitochondrial carrier, palmitoylcarnitine transporter), member 29 | 17.2 | 0 | 1 |
| Solute carrier family 43, member 1 | 17.2 | 0 | 1 |
| Solute carrier family 43, member 2 | 17.2 | 0 | 1 |
| Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 | 17.2 | 0 | 1 |
| Beta-microseminoprotein | 17.2 | 0 | 1 |
| Solute carrier family 38, member 3 | 17.2 | 0 | 1 |
| Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR | 17.2 | 0 | 1 |
| Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids | 17.2 | 0 | 1 |
| VitaPerk | 17.2 | 0 | 1 |
| Kinetica Sports Ltd | 17.2 | 0 | 1 |
| C-X3-C chemokine binding | 17.2 | 0 | 1 |
| regulation of mitochondrial translational initiation | 17.2 | 0 | 1 |
| positive regulation of mitochondrial translational initiation | 17.2 | 0 | 1 |
| negative regulation of mitochondrial translational initiation | 17.2 | 0 | 1 |
| translational readthrough | 17.2 | 0 | 1 |
| viral translational readthrough | 17.2 | 0 | 1 |
| suppression by virus of host translation initiation | 17.2 | 0 | 1 |
| Nutritional Supplements and Ergogenic Aids | 17.2 | 0 | 1 |
| Effect of medium change on the development of in vitro matured and fertilized bovine oocytes cultured in medium containing amino acids | 17.2 | 0 | 1 |
| Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids | 17.2 | 0 | 1 |
| positive regulation of transcription from RNA polymerase II promoter in response to amino acid starvation | 17.2 | 0 | 1 |
| Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions | 17.2 | 0 | 1 |
| Cloning and characterization of a human brain Na(+)-independent transporter for small neutral amino acids that transports D-serine with high affinity | 17.2 | 0 | 1 |
| regulation of dipeptide transport | 17.2 | 0 | 1 |
| sulfur compound catabolic process | 17.2 | 0 | 1 |
| sulfur compound biosynthetic process | 17.2 | 0 | 1 |
| aromatic amino acid family catabolic process | 17.2 | 0 | 1 |
| cellular modified amino acid biosynthetic process | 17.2 | 0 | 1 |
| alkaloid biosynthetic process | 17.2 | 0 | 1 |
| aspartate family amino acid metabolic process | 17.2 | 0 | 1 |
| depsipeptide metabolic process | 17.2 | 0 | 1 |
| depsipeptide catabolic process | 17.2 | 0 | 1 |
| glycopeptide catabolic process | 17.2 | 0 | 1 |
| D-alanine family amino acid metabolic process | 17.2 | 0 | 1 |
| D-alanine family amino acid catabolic process | 17.2 | 0 | 1 |
| anaerobic amino acid catabolic process | 17.2 | 0 | 1 |
| aspartate family amino acid catabolic process | 17.2 | 0 | 1 |
| glutamine family amino acid catabolic process | 17.2 | 0 | 1 |
| amino acid catabolic process to alcohol via Ehrlich pathway | 17.2 | 0 | 1 |
| methionine catabolic process to 3-methylthiopropanol | 17.2 | 0 | 1 |
| amino acid catabolic process to carboxylic acid via Ehrlich pathway | 17.2 | 0 | 1 |
| methionine catabolic process to 3-methylthiopropanoate | 17.2 | 0 | 1 |
| glutamine family amino acid metabolic process | 17.2 | 0 | 1 |
| D-amino acid metabolic process | 17.2 | 0 | 1 |
| branched-chain amino acid catabolic process to alcohol via Ehrlich pathway | 17.2 | 0 | 1 |
| branched-chain amino acid catabolic process to carboxylic acid via Ehrlich pathway | 17.2 | 0 | 1 |
| aromatic amino acid family catabolic process to alcohol via Ehrlich pathway | 17.2 | 0 | 1 |
| aromatic amino acid family catabolic process to carboxylic acid via Ehrlich pathway | 17.2 | 0 | 1 |
| amino acid catabolic process via Ehrlich pathway | 17.2 | 0 | 1 |
| anaerobic catabolism of pairs of amino acids | 17.2 | 0 | 1 |
| aspartate family amino acid biosynthetic process | 17.2 | 0 | 1 |
| D-amino acid biosynthetic process | 17.2 | 0 | 1 |
| glutamine family amino acid biosynthetic process | 17.2 | 0 | 1 |
| D-alanine family amino acid biosynthetic process | 17.2 | 0 | 1 |
| depsipeptide biosynthetic process | 17.2 | 0 | 1 |
| cytoplasmic translation | 17.2 | 0 | 1 |
| plastid translation | 17.2 | 0 | 1 |
| tRNA aminoacylation | 17.2 | 0 | 1 |
| nylon metabolic process | 17.2 | 0 | 1 |
| nylon catabolic process | 17.2 | 0 | 1 |
| metal incorporation into metallo-sulfur cluster | 17.2 | 0 | 1 |
| Lewis a epitope biosynthetic process | 17.2 | 0 | 1 |
| protein modification process in other organism | 17.2 | 0 | 1 |
| protein phosphate-linked glycosylation | 17.2 | 0 | 1 |
| metal incorporation into metallo-oxygen cluster | 17.2 | 0 | 1 |
| co-translational protein acetylation | 17.2 | 0 | 1 |
| CAAX-box protein maturation | 17.2 | 0 | 1 |
| lipoprotein oxidation | 17.2 | 0 | 1 |
| lipoprotein amino acid oxidation | 17.2 | 0 | 1 |
| non-classical arabinogalactan protein metabolic process | 17.2 | 0 | 1 |
| dibasic protein processing | 17.2 | 0 | 1 |
| calcium-dependent self proteolysis | 17.2 | 0 | 1 |
| sodium-dependent self proteolysis | 17.2 | 0 | 1 |
| dipeptide transport | 17.2 | 0 | 1 |
| dipeptide transmembrane transport | 17.2 | 0 | 1 |
| tripeptide transport | 17.2 | 0 | 1 |
| tripeptide transmembrane transport | 17.2 | 0 | 1 |
| amino acid import | 17.2 | 0 | 1 |
| amino acid transmembrane import into vacuole | 17.2 | 0 | 1 |
| basic amino acid transmembrane export from vacuole | 17.2 | 0 | 1 |
| amino acid transmembrane export from vacuole | 17.2 | 0 | 1 |
| neutral amino acid transmembrane import into vacuole | 17.2 | 0 | 1 |
| basic amino acid transmembrane import into vacuole | 17.2 | 0 | 1 |
| neutral amino acid transmembrane export from vacuole | 17.2 | 0 | 1 |
| acidic amino acid transport | 17.2 | 0 | 1 |
| amino acid export across plasma membrane | 17.2 | 0 | 1 |
| basic amino acid transmembrane transport | 17.2 | 0 | 1 |
| sulfur amino acid transport | 17.2 | 0 | 1 |
| extracellular amino acid transport | 17.2 | 0 | 1 |
| negative regulation of amino acid transport | 17.2 | 0 | 1 |
| regulation of amino acid transport | 17.2 | 0 | 1 |
| regulation of peptide transport | 17.2 | 0 | 1 |
| regulation of amino acid import across plasma membrane | 17.2 | 0 | 1 |
| regulation of amino acid export | 17.2 | 0 | 1 |
| regulation of sulfur amino acid metabolic process | 17.2 | 0 | 1 |
| negative regulation of sulfur amino acid metabolic process | 17.2 | 0 | 1 |
| positive regulation of sulfur amino acid metabolic process | 17.2 | 0 | 1 |
| How amino acids get into cells: mechanisms, models, menus, and mediators | 17.2 | 0 | 1 |
| branched-chain amino acids ABC transporter substrate-binding protein PP_1141 | 17.2 | 0 | 1 |
| renal amino acid absorption | 17.2 | 0 | 1 |
| FBXO family protein binding | 17.2 | 0 | 1 |
| endocytic targeting sequence binding | 17.2 | 0 | 1 |
| Branched-chain amino acids ABC transporter substrate-binding protein PP_1141 | 17.2 | 0 | 1 |
| peroxisome membrane targeting sequence binding | 17.2 | 0 | 1 |
| peroxisome membrane class-2 targeting sequence binding | 17.2 | 0 | 1 |
| D-aminoacyl-tRNA deacylase activity | 17.2 | 0 | 1 |
| delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase activity | 17.2 | 0 | 1 |
| jasmonate-amino synthetase activity | 17.2 | 0 | 1 |
| racemase and epimerase activity, acting on amino acids and derivatives | 17.2 | 0 | 1 |
| racemase activity, acting on amino acids and derivatives | 17.2 | 0 | 1 |
| high-affinity basic amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| modified amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| tripeptide transmembrane transporter activity | 17.2 | 0 | 1 |
| dipeptide transmembrane transporter activity | 17.2 | 0 | 1 |
| acidic amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| low-affinity basic amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| sulfur amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| D-amino acid transmembrane transporter activity | 17.2 | 0 | 1 |
| shikimate transmembrane transporter activity | 17.2 | 0 | 1 |
| larval serum protein complex | 17.2 | 0 | 1 |
| amino acid transport complex | 17.2 | 0 | 1 |
| fungal-type vacuole | 17.2 | 0 | 1 |
| starch grain | 17.2 | 0 | 1 |
| chloroplast starch grain | 17.2 | 0 | 1 |
| amyloplast starch grain | 17.2 | 0 | 1 |
| WAViS server for handling, visualization and presentation of multiple alignments of nucleotide or amino acids sequences | 17.2 | 0 | 1 |
| amino acids ABC transporter ATP-binding protein BN112_1113 | 17.2 | 0 | 1 |
| amino acids ABC transporter permease BN112_1112 | 17.2 | 0 | 1 |
| amino acids binding protein BN112_0116 | 17.2 | 0 | 1 |
| amino acids ABC transporter permease BN112_1111 | 17.2 | 0 | 1 |
| amino acids binding protein BP1097 | 17.2 | 0 | 1 |
| possibly related to processing of cell wall amino acids Smed_5041 | 17.2 | 0 | 1 |
| possibly related to processing of cell wall amino acids Smed_5412 | 17.2 | 0 | 1 |
| amino acids ABC transporter ATP-binding protein BN117_3062 | 17.2 | 0 | 1 |
| amino acids ABC transporter permease BN117_3061 | 17.2 | 0 | 1 |
| amino acids ABC transporter permease BN117_3060 | 17.2 | 0 | 1 |
| amino acids binding protein BN117_2166 | 17.2 | 0 | 1 |
| Thermodynamic Properties of Solutions of Amino Acids and Related Substances. III. | 17.2 | 0 | 1 |
| Possibly related to processing of cell wall amino acids Smed_5041 | 17.2 | 0 | 1 |
| Possibly related to processing of cell wall amino acids Smed_5412 | 17.2 | 0 | 1 |
| Category:Chemical synthesis of amino acids | 17.2 | 0 | 1 |
| Amino acids ABC transporter ATP-binding protein BN112_1113 | 17.2 | 0 | 1 |
| Amino acids ABC transporter permease BN112_1112 | 17.2 | 0 | 1 |
| Amino acids binding protein BN112_0116 | 17.2 | 0 | 1 |
| Amino acids ABC transporter permease BN112_1111 | 17.2 | 0 | 1 |
| Amino acids ABC transporter ATP-binding protein BN117_3062 | 17.2 | 0 | 1 |
| Amino acids ABC transporter permease BN117_3061 | 17.2 | 0 | 1 |
| Amino acids ABC transporter permease BN117_3060 | 17.2 | 0 | 1 |
| Amino acids binding protein BN117_2166 | 17.2 | 0 | 1 |
| Amino acids binding protein BP1097 | 17.2 | 0 | 1 |
| Dietary supplements for dysmenorrhoea | 17.2 | 0 | 1 |
| Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration | 17.2 | 0 | 1 |
| Branched-chain amino acids for people with hepatic encephalopathy | 17.2 | 0 | 1 |
| Antifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver disease | 17.2 | 0 | 1 |
| Omega 3 fatty acids for the treatment of dementia | 17.2 | 0 | 1 |
| Branched-chain amino acids for people with hepatic encephalopathy | 17.2 | 0 | 1 |
| Dietary supplements for chronic gout | 17.2 | 0 | 1 |
| Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia | 17.2 | 0 | 1 |
| Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration | 17.2 | 0 | 1 |
| Dietary supplements for chronic gout | 17.2 | 0 | 1 |
| Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease | 17.2 | 0 | 1 |
| Antifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver disease | 17.2 | 0 | 1 |
| Early versus late administration of amino acids in preterm infants receiving parenteral nutrition | 17.2 | 0 | 1 |
| Omega 3 fatty acid supplementation for preventing and slowing the progression of age-related macular degeneration | 17.2 | 0 | 1 |
| Omega 3 fatty acid for the prevention of cognitive decline and dementia | 17.2 | 0 | 1 |
| Dietary supplements for preventing postnatal depression | 17.2 | 0 | 1 |
| Dietary supplements for established atopic eczema | 17.2 | 0 | 1 |
| Omega 3 fatty acids for the treatment of dementia and cognitive impairment | 17.2 | 0 | 1 |
| Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adults | 17.2 | 0 | 1 |
| Dietary supplements for preventing postnatal depression | 17.2 | 0 | 1 |
| Early versus late administration of amino acids in preterm infants receiving parenteral nutrition | 17.2 | 0 | 1 |
| Nutritional supplements for people being treated for active tuberculosis | 17.2 | 0 | 1 |
| Nutritional supplements for people being treated for active tuberculosis | 17.2 | 0 | 1 |
| Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease | 17.2 | 0 | 1 |
| Amino acids for amyotrophic lateral sclerosis / motor neuron disease | 17.2 | 0 | 1 |
| Amino acids for amyotrophic lateral sclerosis / motor neuron disease | 17.2 | 0 | 1 |
| Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease | 17.2 | 0 | 1 |
| Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis | 17.2 | 0 | 1 |
| Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease | 17.2 | 0 | 1 |
| Dietary supplements for established atopic eczema | 17.2 | 0 | 1 |
| Omega 3 fatty acid for the prevention of dementia | 17.2 | 0 | 1 |
| Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease | 17.2 | 0 | 1 |
| Omega 3 fatty acids for prevention and treatment of cardiovascular disease | 17.2 | 0 | 1 |
| Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis | 17.2 | 0 | 1 |
| Dietary supplements for established atopic eczema | 17.2 | 0 | 1 |
| Nutritional supplements for people being treated for active tuberculosis | 17.2 | 0 | 1 |
| Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease | 17.2 | 0 | 1 |
| Omega 3 fatty acid for the prevention of dementia | 17.2 | 0 | 1 |
| Amino acids for amyotrophic lateral sclerosis / motor neuron disease | 17.2 | 0 | 1 |
| Branched-chain amino acids for hepatic encephalopathy | 17.2 | 0 | 1 |
| Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin | 17.2 | 0 | 1 |
| Single amino acids in the carboxyl terminal domain of aquaporin-1 contribute to cGMP-dependent ion channel activation | 17.2 | 0 | 1 |
| Recognition of C-terminal amino acids in tubulin by pore loops in Spastin is important for microtubule severing | 17.2 | 0 | 1 |
| The cytosolic carboxypeptidases CCP2 and CCP3 catalyze posttranslational removal of acidic amino acids | 17.2 | 0 | 1 |
| Reabsorption of neutral amino acids mediated by amino acid transporter LAT2 and TAT1 in the basolateral membrane of proximal tubule | 17.2 | 0 | 1 |
| Specific amino acids in the BAR domain allow homodimerization and prevent heterodimerization of sorting nexin 33 | 17.2 | 0 | 1 |
| Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids | 17.2 | 0 | 1 |
| Filamin binds to the cytoplasmic domain of the beta1-integrin. Identification of amino acids responsible for this interaction | 17.2 | 0 | 1 |
| Identification of amino acids in the N-terminal SH2 domain of phospholipase C gamma 1 important in the interaction with epidermal growth factor receptor | 17.2 | 0 | 1 |
| Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue | 17.2 | 0 | 1 |
| Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase | 17.2 | 0 | 1 |
| The deletion of 14 amino acids in the seventh transmembrane domain of a naturally occurring calcitonin receptor isoform alters ligand binding and selectively abolishes coupling to phospholipase C | 17.2 | 0 | 1 |
| Amino acids C-terminal to the 14-3-3 binding motif in CDC25B affect the efficiency of 14-3-3 binding | 17.2 | 0 | 1 |
| Essential amino acids for substrate binding and catalysis of human flap endonuclease 1 | 17.2 | 0 | 1 |
| LOC100911244 | 17.2 | 0 | 1 |
| Influence of dietary protein supplements on the formation of bacterial metabolites in the colon | 17.2 | 0 | 1 |
| Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins | 17.2 | 0 | 1 |
| Identification by site-directed mutagenesis of amino acids contributing to ligand-binding specificity or signal transduction properties of the human FP prostanoid receptor | 17.2 | 0 | 1 |
| THE PERIODATE OXIDATION OF AMINO ACIDS WITH REFERENCE TO STUDIES ON GLYCOPROTEINS | 17.2 | 0 | 1 |
| Q24535706 | 17.2 | 0 | 1 |
| Jasmonate-inducible plant enzymes degrade essential amino acids in the herbivore midgut | 17.2 | 0 | 1 |
| Invariant amino acids essential for decoding function of polypeptide release factor eRF1. | 17.2 | 0 | 1 |
| Correlation between the distribution of amino acids and alpha helices | 17.2 | 0 | 1 |
| The SBP2 and 15.5 kD/Snu13p proteins share the same RNA binding domain: identification of SBP2 amino acids important to SECIS RNA binding | 17.2 | 0 | 1 |
| Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review | 17.2 | 0 | 1 |
| Mutational analysis of Escherichia coli DNA ligase identifies amino acids required for nick-ligation in vitro and for in vivo complementation of the growth of yeast cells deleted for CDC9 and LIG4 | 17.2 | 0 | 1 |
| The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest | 17.2 | 0 | 1 |
| Replacement of two non-adjacent amino acids in the S.cerevisiae bi2 intron-encoded RNA maturase is sufficient to gain a homing-endonuclease activity | 17.2 | 0 | 1 |
| Amino acids as regulators of gene expression | 17.2 | 0 | 1 |
| Identification of catalytically relevant amino acids of the extracellular Serratia marcescens endonuclease by alignment-guided mutagenesis | 17.2 | 0 | 1 |
| Operational RNA code for amino acids: species-specific aminoacylation of minihelices switched by a single nucleotide | 17.2 | 0 | 1 |
| Nonprotein amino acids from spark discharges and their comparison with the murchison meteorite amino acids | 17.2 | 0 | 1 |
| Prebiotic Synthesis of Hydrophobic and Protein Amino Acids | 17.2 | 0 | 1 |
| Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria | 17.2 | 0 | 1 |
| Pattern of aromatic and hydrophobic amino acids critical for one of two subdomains of the VP16 transcriptional activator | 17.2 | 0 | 1 |
| Vitamin B₁₂-containing plant food sources for vegetarians | 17.2 | 0 | 1 |
| A therapeutic trial of pro-methylation dietary supplements in Angelman syndrome | 17.2 | 0 | 1 |
| The human Oct-6 POU transcription factor lacks the first 50 amino acids of its murine counterpart | 17.2 | 0 | 1 |
| Genetic code supports targeted insertion of two amino acids by one codon | 17.2 | 0 | 1 |
| The Ras protein superfamily: evolutionary tree and role of conserved amino acids | 17.2 | 0 | 1 |
| Nutritional supplements for age-related macular degeneration | 17.2 | 0 | 1 |
| Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria | 17.2 | 0 | 1 |
| Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlled, randomized clinical trial | 17.2 | 0 | 1 |
| Stronger is not always better: could a bodybuilding dietary supplement lead to ALS? | 17.2 | 0 | 1 |
| A facile system for encoding unnatural amino acids in mammalian cells | 17.2 | 0 | 1 |
| General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids | 17.2 | 0 | 1 |
| Spatial regulation of the mTORC1 system in amino acids sensing pathway | 17.2 | 0 | 1 |
| Primordial synthesis of amines and amino acids in a 1958 Miller H2S-rich spark discharge experiment | 17.2 | 0 | 1 |
| Nonprotein amino acids in the murchison meteorite | 17.2 | 0 | 1 |
| Transamination of D-amino acids by Bacillus subtilis | 17.2 | 0 | 1 |
| Extraterrestrial amino acids in Orgueil and Ivuna: tracing the parent body of CI type carbonaceous chondrites | 17.2 | 0 | 1 |
| Role of minimization of chemical distances between amino acids in the evolution of the genetic code | 17.2 | 0 | 1 |
| Synthesis of site-specific antibody-drug conjugates using unnatural amino acids | 17.2 | 0 | 1 |
| The Dietary Supplement Protandim® Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular DystrophyMdxMice | 17.2 | 0 | 1 |
| Products of two common alleles at the locus for human placental alkaline phosphatase differ by seven amino acids | 17.2 | 0 | 1 |
| Identification and characterization of a lysosomal transporter for small neutral amino acids | 17.2 | 0 | 1 |
| Rapid Analytical Method for the Determination of Aflatoxins in Plant-Derived Dietary Supplement and Cosmetic Oils | 17.2 | 0 | 1 |
| Amino acids and muscle loss with aging | 17.2 | 0 | 1 |
| Metabolism of sulfur amino acids in Saccharomyces cerevisiae | 17.2 | 0 | 1 |
| Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids | 17.2 | 0 | 1 |
| Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids | 17.2 | 0 | 1 |
| Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation | 17.2 | 0 | 1 |
| Botanical dietary supplements gone bad | 17.2 | 0 | 1 |
| Quantitative phosphotyrosine proteomics of EphB2 signaling by stable isotope labeling with amino acids in cell culture (SILAC) | 17.2 | 0 | 1 |
| Site-directed mutagenesis of the proposed catalytic amino acids of the Sindbis virus capsid protein autoprotease | 17.2 | 0 | 1 |
| Genetically encoding unnatural amino acids for cellular and neuronal studies | 17.2 | 0 | 1 |
| STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature | 17.2 | 0 | 1 |
| Closed-system behaviour of the intra-crystalline fraction of amino acids in mollusc shells | 17.2 | 0 | 1 |
| The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids | 17.2 | 0 | 1 |
| Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity | 17.2 | 0 | 1 |
| The transcriptional activator GCN4 contains multiple activation domains that are critically dependent on hydrophobic amino acids | 17.2 | 0 | 1 |
| Role of S3 and S4 transmembrane domain charged amino acids in channel biogenesis and gating of KCa2.3 and KCa3.1 | 17.2 | 0 | 1 |
| Determination of chondroitin sulfate content in raw materials and dietary supplements by high-performance liquid chromatography with ultraviolet detection after enzymatic hydrolysis: single-laboratory validation | 17.2 | 0 | 1 |
| Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States | 17.2 | 0 | 1 |
| INCORPORATION OF C14 FROM CARBON DIOXIDE INTO SUGAR PHOSPHATES, CARBOXYLIC ACIDS, AND AMINO ACIDS BY CLOSTRIDIUM THERMOACETICUM | 17.2 | 0 | 1 |
| Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential | 17.2 | 0 | 1 |
| Total folate and folic acid intake from foods and dietary supplements in the United States: 2003-2006 | 17.2 | 0 | 1 |
| Assessing potential health risks from microcystin toxins in blue-green algae dietary supplements | 17.2 | 0 | 1 |
| Amino acids in the Martian meteorite Nakhla | 17.2 | 0 | 1 |
| Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia | 17.2 | 0 | 1 |
| N‐ and C‐capping preferences for all 20 amino acids in α‐helical peptides | 17.2 | 0 | 1 |
| CDC7 kinase phosphorylates serine residues adjacent to acidic amino acids in the minichromosome maintenance 2 protein | 17.2 | 0 | 1 |
| Identification of essential amino acids in the Streptococcus mutans glucosyltransferases | 17.2 | 0 | 1 |
| Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial | 17.2 | 0 | 1 |
| The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study | 17.2 | 0 | 1 |
| Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids | 17.2 | 0 | 1 |
| Nutritional supplement chromium picolinate causes sterility and lethal mutations in Drosophila melanogaster | 17.2 | 0 | 1 |
| Site-directed mutagenesis of conserved amino acids in the alpha subunit of toluene dioxygenase: potential mononuclear non-heme iron coordination sites | 17.2 | 0 | 1 |
| High content of proteins containing 21st and 22nd amino acids, selenocysteine and pyrrolysine, in a symbiotic deltaproteobacterium of gutless worm Olavius algarvensis | 17.2 | 0 | 1 |
| Effects of eight weeks of an alleged aromatase inhibiting nutritional supplement 6-OXO (androst-4-ene-3,6,17-trione) on serum hormone profiles and clinical safety markers in resistance-trained, eugonadal males | 17.2 | 0 | 1 |
| Sources of mycosporine-like amino acids in planktonic Chlorella-bearing ciliates (Ciliophora) | 17.2 | 0 | 1 |
| Large neutral amino acids transporter small subunit 4 | 17.2 | 0 | 1 |
| Specific amino acids and opine-binding periplasmic protein, ABC transporter | 17.2 | 0 | 1 |
| Filament-like plant protein | 17.2 | 0 | 1 |
| Feeding of soy protein isolate to rats during pregnancy and lactation suppresses formation of aberrant crypt foci in their progeny's colons: interaction of diet with fetal alcohol exposure | 17.2 | 0 | 1 |
| Mutation of exposed hydrophobic amino acids to arginine to increase protein stability | 17.2 | 0 | 1 |
| Use of dietary supplements by female seniors in a large Northern California health plan | 17.2 | 0 | 1 |
| Role of lipid peroxidation and antioxidant enzymes in omega 3 fatty acids induced suppression of breast cancer xenograft growth in mice | 17.2 | 0 | 1 |
| Insertion of a small peptide of six amino acids into the beta7-beta8 loop of the p51 subunit of HIV-1 reverse transcriptase perturbs the heterodimer and affects its activities | 17.2 | 0 | 1 |
| Dietary analysis and patterns of nutritional supplement use in normal and age-related macular disease affected subjects: a prospective cross-sectional study | 17.2 | 0 | 1 |
| One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women | 17.2 | 0 | 1 |
| Binding of pRNA to the N-terminal 14 amino acids of connector protein of bacteriophage phi29 | 17.2 | 0 | 1 |
| Are herbal remedies and dietary supplements safe and effective for breast cancer patients? | 17.2 | 0 | 1 |
| Phytochemical Assays of Commercial Botanical Dietary Supplements | 17.2 | 0 | 1 |
| transAlign: using amino acids to facilitate the multiple alignment of protein-coding DNA sequences | 17.2 | 0 | 1 |
| A computational method to predict genetically encoded rare amino acids in proteins | 17.2 | 0 | 1 |
| sulfur-containing amino acid | 17.2 | 0 | 1 |
| hemp protein | 17.2 | 0 | 1 |
| Mellin's Food | 17.2 | 0 | 1 |
| In vitro selection of tRNAs for efficient four-base decoding to incorporate non-natural amino acids into proteins in an Escherichia coli cell-free translation system | 17.2 | 0 | 1 |
| The role of positively charged amino acids and electrostatic interactions in the complex of U1A protein and U1 hairpin II RNA | 17.2 | 0 | 1 |
| Four-base codon mediated mRNA display to construct peptide libraries that contain multiple nonnatural amino acids | 17.2 | 0 | 1 |
| Conservative mutation | 17.2 | 0 | 1 |
| Category:Non-proteinogenic amino acids | 17.2 | 0 | 1 |
| Template:WikiProject Dietary Supplements | 17.2 | 0 | 1 |
| Molecular classification based on apomorphic amino acids (Arthropoda, Hexapoda): Integrative taxonomy in the era of phylogenomics | 17.2 | 0 | 1 |
| Nutritional supplements for people being treated for active tuberculosis | 17.2 | 0 | 1 |
| Nutritional supplements for patients being treated for active visceral leishmaniasis | 17.2 | 0 | 1 |
| Oral nutritional supplements for treating venous leg ulcers | 17.2 | 0 | 1 |
| Meteoritic Amino Acids: Diversity in Compositions Reflects Parent Body Histories | 17.2 | 0 | 1 |
| Effects of Physical Exercise Combined with Nutritional Supplements on Aging Brain Related Structures and Functions: A Systematic Review | 17.2 | 0 | 1 |
| Emerging Evidence for the Importance of Dietary Protein Source on Glucoregulatory Markers and Type 2 Diabetes: Different Effects of Dairy, Meat, Fish, Egg, and Plant Protein Foods | 17.2 | 0 | 1 |
| Recent Advances in Substrate-Controlled Asymmetric Induction Derived from Chiral Pool α-Amino Acids for Natural Product Synthesis | 17.2 | 0 | 1 |
| Adherence to ketoacids/essential amino acids-supplemented low protein diets and new indications for patients with chronic kidney disease | 17.2 | 0 | 1 |
| The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism | 17.2 | 0 | 1 |
| Roles of d-Amino Acids on the Bioactivity of Host Defense Peptides | 17.2 | 0 | 1 |
| Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics | 17.2 | 0 | 1 |
| Amino acids and mammary gland development: nutritional implications for milk production and neonatal growth | 17.2 | 0 | 1 |
| Regulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glance | 17.2 | 0 | 1 |
| Prescription Omega-3 Fatty Acid Products and Dietary Supplements Are Not Interchangeable | 17.2 | 0 | 1 |
| Plant protein glycosylation | 17.2 | 0 | 1 |
| Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States | 17.2 | 0 | 1 |
| Effect of Nutrients, Dietary Supplements and Vitamins on Cognition: a Systematic Review and Meta-Analysis of Randomized Controlled Trials | 17.2 | 0 | 1 |
| Mycosporine-Like Amino Acids and Their Derivatives as Natural Antioxidants | 17.2 | 0 | 1 |
| Dairy proteins and soy proteins in infant foods nitrogen-to-protein conversion factors | 17.2 | 0 | 1 |
| Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents | 17.2 | 0 | 1 |
| Amino acids in the cultivation of mammalian cells | 17.2 | 0 | 1 |
| Effects of Flavonoids from Food and Dietary Supplements on Glial and Glioblastoma Multiforme Cells | 17.2 | 0 | 1 |
| Role of creatine supplementation in exercise-induced muscle damage: A mini review | 17.2 | 0 | 1 |
| Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review | 17.2 | 0 | 1 |
| Ubiquitylation of an ERAD Substrate Occurs on Multiple Types of Amino Acids | 17.2 | 0 | 1 |
| Amino acids in sandal (Santalum album L) with special reference to cis-4-hydroxy-l-proline and sym. homospermidine | 17.2 | 0 | 1 |
| Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia? | 17.2 | 0 | 1 |
| Lipidomics to Assess Omega 3 Bioactivity | 17.2 | 0 | 1 |
| Clays as dietary supplements for swine: A review | 17.2 | 0 | 1 |
| Nutritional Supplements in Support of Resistance Exercise to Counter Age-Related Sarcopenia | 17.2 | 0 | 1 |
| International society of sports nutrition position stand: Beta-Alanine | 17.2 | 0 | 1 |
| Bioactive compounds derived from the yeast metabolism of aromatic amino acids during alcoholic fermentation | 17.2 | 0 | 1 |
| Dietary Supplements and Hypertension: Potential Benefits and Precautions | 17.2 | 0 | 1 |
| Cotranslational incorporation of non‐standard amino acids using cell‐free protein synthesis | 17.2 | 0 | 1 |
| Use of Time-Resolved Fluorescence to Monitor Bioactive Compounds in Plant Based Foodstuffs | 17.2 | 0 | 1 |
| Proposed profile of omega 3 fatty acids in enteral nutrition | 17.2 | 0 | 1 |
| Increased Glutamate and Homocysteine and Decreased Glutamine Levels in Autism: A Review and Strategies for Future Studies of Amino Acids in Autism | 17.2 | 0 | 1 |
| Journal of Amino Acids | 17.2 | 0 | 1 |
| Interplay between lipids and branched-chain amino acids in development of insulin resistance | 17.2 | 0 | 1 |
| Surfactant modified/mediated thin-layer chromatographic systems for the analysis of amino acids | 17.2 | 0 | 1 |
| Nutrition and metabolism in hepatocellular carcinoma | 17.2 | 0 | 1 |
| Q26863305 | 17.2 | 0 | 1 |
| Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids | 17.2 | 0 | 1 |
| Activity of selected aromatic amino acids in biological systems | 17.2 | 0 | 1 |
| Dietary supplements as a treatment for cervical cancer: a systematic review | 17.2 | 0 | 1 |
| Plastidic aspartate aminotransferases and the biosynthesis of essential amino acids in plants | 17.2 | 0 | 1 |
| Dietary requirements of synthesizable amino acids by animals: a paradigm shift in protein nutrition | 17.2 | 0 | 1 |
| Fortifying plants with the essential amino acids lysine and methionine to improve nutritional quality | 17.2 | 0 | 1 |
| Estimating caffeine intake from energy drinks and dietary supplements in the United States | 17.2 | 0 | 1 |
| Influence of Amino Acids, Dietary Protein, and Physical Activity on Muscle Mass Development in Humans | 17.2 | 0 | 1 |
| Amino acids and mTORC1: from lysosomes to disease | 17.2 | 0 | 1 |
| Sulfur Amino Acids in Diet-induced Fatty Liver: A New Perspective Based on Recent Findings | 17.2 | 0 | 1 |
| Dietary approaches for management of cardio-vascular health- a review | 17.2 | 0 | 1 |
| Amino acids in the rhizosphere: From plants to microbes | 17.2 | 0 | 1 |
| Development of Stimulus-responsive Amino Acids and Their Application to Chemical Biology Use | 17.2 | 0 | 1 |
| Diet and psoriasis, part III: role of nutritional supplements | 17.2 | 0 | 1 |
| Radiolabeled Amino Acids for Oncologic Imaging | 17.2 | 0 | 1 |
| Reactive oxygen and nitrogen species generation, antioxidant defenses, and β-cell function: a critical role for amino acids | 17.2 | 0 | 1 |
| Role of specific dietary amino acids in clinical conditions | 17.2 | 0 | 1 |
| Regulation of mTORC1 by amino acids | 17.2 | 0 | 1 |
| creatine monohydrate | 17.2 | 0 | 1 |
| Membrane Topology and Predicted RNA-Binding Function of the ‘Early Responsive to Dehydration (ERD4)’ Plant Protein | 17.2 | 0 | 1 |
| Moss Chloroplasts Are Surrounded by a Peptidoglycan Wall Containing D-Amino Acids | 17.2 | 0 | 1 |
| Lipid profiling following intake of the omega 3 fatty acid DHA identifies the peroxidized metabolites F4-neuroprostanes as the best predictors of atherosclerosis prevention | 17.2 | 0 | 1 |
| The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids | 17.2 | 0 | 1 |
| Modification of the 5' terminus of Sindbis virus genomic RNA allows nsP4 RNA polymerases with nonaromatic amino acids at the N terminus to function in RNA replication | 17.2 | 0 | 1 |
| Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones | 17.2 | 0 | 1 |
| A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity | 17.2 | 0 | 1 |
| Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complement-mediated cytolytic activity | 17.2 | 0 | 1 |
| Causality assessment in hepatotoxicity by drugs and dietary supplements | 17.2 | 0 | 1 |
| International Society of Sports Nutrition position stand: meal frequency | 17.2 | 0 | 1 |
| Clostridium thermocellum Xyn10B carbohydrate-binding module 22-2: the role of conserved amino acids in ligand binding | 17.2 | 0 | 1 |
| Protease C of Erwinia chrysanthemi: the crystal structure and role of amino acids Y228 and E189 | 17.2 | 0 | 1 |
| The coiled coil region (amino acids 129-250) of the tumor suppressor protein adenomatous polyposis coli (APC). Its structure and its interaction with chromosome maintenance region 1 (Crm-1) | 17.2 | 0 | 1 |
| Solvent exposed non-contacting amino acids play a critical role in NF-kappaB/IkappaBalpha complex formation | 17.2 | 0 | 1 |
| High precision NMR structure and function of the RING-H2 finger domain of EL5, a rice protein whose expression is increased upon exposure to pathogen-derived oligosaccharides | 17.2 | 0 | 1 |
| Structural studies of hydrogen bonds in the high-affinity streptavidin-biotin complex: mutations of amino acids interacting with the ureido oxygen of biotin | 17.2 | 0 | 1 |
| Biochemical and Structural Characterization of the Secreted Chorismate Mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv: an *AroQ Enzyme Not Regulated by the Aromatic Amino Acids | 17.2 | 0 | 1 |
| Crystal structure of the multidrug efflux transporter AcrB at 3.1Å resolution reveals the N-terminal region with conserved amino acids | 17.2 | 0 | 1 |
| Structure of 2-amino-3,7-dideoxy-D-threo-hept-6-ulosonic acid synthase, a catalyst in the archaeal pathway for the biosynthesis of aromatic amino acids | 17.2 | 0 | 1 |
| Structure of a designed, right-handed coiled-coil tetramer containing all biological amino acids | 17.2 | 0 | 1 |
| Identification and characterization of two amino acids critical for the substrate inhibition of human dehydroepiandrosterone sulfotransferase (SULT2A1) | 17.2 | 0 | 1 |
| Tandem use of X-ray crystallography and mass spectrometry to obtain ab initio the complete and exact amino acids sequence of HPBP, a human 38-kDa apolipoprotein | 17.2 | 0 | 1 |
| Effect of Mutation of Carboxyl Side-Chain Amino Acids Near the Heme on the Midpoint Potentials and Ligand Binding Constants of Nitrophorin 2 and Its NO, Histamine, and Imidazole Complexes | 17.2 | 0 | 1 |
| Contributions of all 20 amino acids at site 96 to the stability and structure of T4 lysozyme | 17.2 | 0 | 1 |
| Annotating Enzymes of Uncertain Function: The Deacylation of d -Amino Acids by Members of the Amidohydrolase Superfamily , | 17.2 | 0 | 1 |
| 2-Aminoimidazole Amino Acids as Inhibitors of the Binuclear Manganese Metalloenzyme Human Arginase I | 17.2 | 0 | 1 |
| Probing the active site of MIO-dependent aminomutases, key catalysts in the biosynthesis of β-amino acids incorporated in secondary metabolites | 17.2 | 0 | 1 |
| Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin | 17.2 | 0 | 1 |
| Identification of Amino Acids that Account for Long-Range Interactions in Two Triosephosphate Isomerases from Pathogenic Trypanosomes | 17.2 | 0 | 1 |
| Stereochemical Basis for Engineered Pyrrolysyl-tRNA Synthetase and the Efficient in Vivo Incorporation of Structurally Divergent Non-native Amino Acids | 17.2 | 0 | 1 |
| Binding of α,α-Disubstituted Amino Acids to Arginase Suggests New Avenues for Inhibitor Design | 17.2 | 0 | 1 |
| Simplification of the genetic code: restricted diversity of genetically encoded amino acids | 17.2 | 0 | 1 |
| Incorporation of Non-natural Amino Acids Improves Cell Permeability and Potency of Specific Inhibitors of Proteasome Trypsin-like Sites | 17.2 | 0 | 1 |
| Simplified protein design biased for prebiotic amino acids yields a foldable, halophilic protein | 17.2 | 0 | 1 |
| Engineering methylaspartate ammonia lyase for the asymmetric synthesis of unnatural amino acids | 17.2 | 0 | 1 |
| Insights into Aurora-A Kinase Activation Using Unnatural Amino Acids Incorporated by Chemical Modification | 17.2 | 0 | 1 |
| Charged Amino Acids (R83, E567, D617, E625, R669, and K678) of CusA Are Required for Metal Ion Transport in the Cus Efflux System | 17.2 | 0 | 1 |
| An improved racemase/acylase biotransformation for the preparation of enantiomerically pure amino acids | 17.2 | 0 | 1 |
| Selective detection of caspase-3 versus caspase-7 using activity-based probes with key unnatural amino acids | 17.2 | 0 | 1 |
| Improving binding affinity and stability of peptide ligands by substituting glycines with D-amino acids | 17.2 | 0 | 1 |
| Different contribution of conserved amino acids to the global properties of triosephosphate isomerases | 17.2 | 0 | 1 |
| Structural insights into incorporation of norbornene amino acids for click modification of proteins | 17.2 | 0 | 1 |
| The Formation of Pyrroline and Tetrahydropyridine Rings in Amino Acids Catalyzed by Pyrrolysine Synthase (PylD) | 17.2 | 0 | 1 |
| Selective inhibition of initiator versus executioner caspases using small peptides containing unnatural amino acids | 17.2 | 0 | 1 |